(2E,4E,6Z)-7-[(3R,6S)-6-(1-Methylethyl)-3-methylcyclohexen-1-yl]-3-methyl-2,4,6-octatrienoic acid

ID: ALA1773361

PubChem CID: 54586043

Max Phase: Preclinical

Molecular Formula: C19H28O2

Molecular Weight: 288.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C/C(=C/C=C/C(C)=C/C(=O)O)C1=C[C@H](C)CC[C@H]1C(C)C

Standard InChI:  InChI=1S/C19H28O2/c1-13(2)17-10-9-15(4)11-18(17)16(5)8-6-7-14(3)12-19(20)21/h6-8,11-13,15,17H,9-10H2,1-5H3,(H,20,21)/b7-6+,14-12+,16-8-/t15-,17+/m1/s1

Standard InChI Key:  CJBRTDXJWUGFOW-XVZFVHJYSA-N

Molfile:  

     RDKit          2D

 21 21  0  0  0  0  0  0  0  0999 V2000
    1.8125   -1.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6625   -4.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6625   -5.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2375   -2.6708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9500   -3.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5250   -1.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9500   -3.0833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2375   -1.8458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3750   -5.5625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9458   -5.5583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2333   -4.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5333   -0.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8125   -2.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000   -1.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3917   -1.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3917   -2.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000   -3.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0989   -0.5958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8129   -0.1824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3839   -0.1842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0989   -3.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10  3  1  0
 11  5  1  0
 12  6  1  0
  2  5  2  0
  3  2  1  0
  4  8  1  0
 13  1  2  0
 14  1  1  0
 17 13  1  0
 15 14  1  0
 16 15  1  0
 16 17  1  0
  5  7  1  0
  6  1  1  0
 14 18  1  1
  7  4  2  0
 18 19  1  0
  8  6  2  0
 18 20  1  0
  9  3  2  0
 17 21  1  6
M  END

Associated Targets(Human)

RARB Tclin Retinoic acid receptor beta (1232 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Crabp2 Cellular retinoic acid-binding protein II (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 288.43Molecular Weight (Monoisotopic): 288.2089AlogP: 5.15#Rotatable Bonds: 5
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 1HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.41CX Basic pKa: CX LogP: 4.96CX LogD: 2.08
Aromatic Rings: Heavy Atoms: 21QED Weighted: 0.56Np Likeness Score: 2.02

References

1. Okitsu T, Sato K, Iwatsuka K, Sawada N, Nakagawa K, Okano T, Yamada S, Kakuta H, Wada A..  (2011)  Replacement of the hydrophobic part of 9-cis-retinoic acid with cyclic terpenoid moiety results in RXR-selective agonistic activity.,  19  (9): [PMID:21489804] [10.1016/j.bmc.2011.03.033]

Source